Biogen wants approval of Tysabri for Crohn's disease
San Antonio Business Journal - San Antonio,
TX,USA ... Tysabri was cleared to return to
market in July, with restrictions, after previous
clinical data was reevaluated, giving Cambridge,
Mass.-based Biogen Idec and ...

Elan and Biogen Idec Submit Supplemental Biologics License ...
PharmaLive.com (press release) - Newtown,PA,USA
... of a supplemental Biologics License Application
(sBLA) to the US Food and Drug Administration
(FDA) seeking approval to market TYSABRI(R) (natalizumab) in the ...

UPDATE 1-Elan, Biogen jump on Crohn's filing for Tysabri
Reuters - USA
... and Biogen Idec on Friday said they asked
US regulators to approve use of their multiple
sclerosis drug Tysabri, which has been hurt by
safety concerns, to ...

Elan, Biogen seek Tysabri OK for Crohn's
United Press International - USA
15 (UPI) -- Irish firm Elan and US drug maker
Biogen Idec said Friday they are seeking approval
of multiple-sclerosis drug Tysabri for Crohn's
disease. ...
See all stories on this topic

Elan wants to use Tysabri to treat Crohn's
RTE.ie - Ireland
Elan Corporation and Biogen Idec said today that
they have asked US regulators to approve use of their
multiple sclerosis drug Tysabri, which has been
hounded ...